Patient-Reported Outcomes With First-Line Immunotherapy-Based Combination Treatment for Advanced Lung Cancer: A Prospective, Multicenter, Observational Study.

Thorac Cancer · 2025 · PMC12445973 · PMID 40968101

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

showed a trendp < 0.001actually significant

Coughing, which had the highest baseline occurrence rate and severity, showed a trend of gradual attenuation with ongoing immunotherapy‐based combination treatment ( p < 0.001).

also in 53,322 other papers

an increasing trendno p-value reported

They then persisted throughout the entire treatment period, with an increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.